David Bogoslaw

Late-stage fundraising is driving fund size, as former IPO investors continue to show interest in earlier fundraising stages and write bigger checks

US venture funds sitting on a record $290bn in dry powder pumped the brakes on dealmaking in the second quarter.

As economic troubles continue to roil the world’s biggest economies, VCs are thriving in a European market where $1bn-plus unicorns are making quite a splash.

With local teams in offices on almost every continent, Headline announced that it has raised a total of $954 million across three distinct early-stage funds that will invest in consumer and B2B start-ups in North America, Europe and Brazil.

The fact that three firms led by women raised multi-billion funds within a couple of months is worth celebrating, but female-led VC funds still account for only a fraction of the industry.

In light of economic stressors, LPs are asking themselves if they should pull back from private assets or just sit tight.

Women-focused venture capital firm True Wealth Ventures has closed its second fund at $35 million, noting that the vehicle was oversubscribed.

A new venture fund takes an impact investing approach to address structural impediments LGBTQ+ founders confront in fundraising.

Life sciences investor Catalio Capital Management has been on a fundraising tear since it spun out of private equity firm Camden Partners Holdings slightly more than two years ago. If dealmaking continues to founder in a sputtering economy, Catalio will be well positioned to take advantage of declining valuations.

The Column Group is close to reaching its fundraising target of $600m apiece for its early-stage life science Fund V and later-stage Opportunity Fund III.